Joseph Michael Fitzgerald, EVP & Group President, Cardiology at BOSTON SCIENTIFIC CORP (BSX), sold 92,848 shares at $57.50 ($5.3M) on 2023-12-29, disclosed to the SEC on 2024-01-02.
Seasonal sale ($5.3M) by EVP & Group President, Cardiology — this insider has traded BSX in December in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.50 | 81,940 | $4.7M | 88.2% |
| 2 | $57.81 | 10,908 | $631K | 11.8% |
| Total | $57.54 avg | 92,848 | $5.3M | 100% |
| Filing → |
| BSX | SELL | 2025-09-03 | $10.5M | — | Filing → |
| BSX | SELL | 2025-08-04 | $5.2M | — | Filing → |
| BSX | SELL | 2025-07-02 | $5.3M | — | Filing → |